3 studies found for:    Alzheimer's | baxter [Lead]
Show Display Options
Rank Status Study
1 Completed A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%);   Other: Placebo solution
2 Terminated Phase 3 IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Interventions: Biological: Immune Globulin Intravenous (Human), 10% Solution;   Biological: Human albumin 0.25%
3 Terminated Long-Term Study of IGIV, 10% in Alzheimer´s Disease
Condition: Alzheimer´s Disease
Intervention: Drug: Immune Globulin Intravenous (Human), 10% (IGIV, 10%)

Indicates status has not been verified in more than two years